International journal of environmental research and public health

arerugi = [allergy]

pakistan journal of medical sciences

european journal of case reports in internal medicine

enfermedades infecciosas y microbiologia clinica

[1] Risk factors for mortality among inpatients with smear positive pulmonary tuberculosis.

[2] The Reversed Halo Sign: Not Such a Specific Sign of Organising Pneumonia.

[3] Tuberculosis in the paediatric population of Madrid in the last 26 years.

[4] Tuberculosis-Related Hospitalizations in a Low-Incidence Country: A Retrospective Analysis in Two Italian Infectious Diseases Wards.

[5] evaluation of p2x7 and ifn-γ gene polymorphisms in patients with pulmonary tuberculosis using pcr-rflp method

[6] a case of pulmonary carcinoid tumor with concomitant tuberculosis

[7] imaging in tuberculosis

[8] immunologic evaluation and validation of methods using synthetic peptides derived from mycobacterium tuberculosis for the diagnosis of tuberculosis infection

[9] rasmussen's aneurysm: a forgotten scourge

[10] situación de la tuberculosis en colombia, 2002.

[11] association between health-related quality of life and medication adherence in pulmonary tuberculosis in south africa

[12] wegener′s granulomatosis disease mimicking pulmonary tuberculosis

[13] intervals before tuberculosis diagnosis and isolation at a regional hospital in taiwan

[14] pathomorphological features of pulmonary tuberculoma (according to the analysis of operational resection material)

[15] Observation of Lower Urinary Tract Symptoms and Other Signs of Benign Prostatic Hyperplasia in Patients with Tuberculosis

[16] Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses

[17] Association of MBL2 gene polymorphisms with pulmonary tuberculosis susceptibility: trial sequence meta-analysis as evidence

[18] Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones

[19] Sera from patients with active pulmonary tuberculosis and their household contacts induce nuclear changes in neutrophils

[20] The correlation between CT features and glycosylated hemoglobin level in patients with T2DM complicated with primary pulmonary tuberculosis

[21] Performance of computed tomography versus chest radiography in patients with pulmonary tuberculosis with and without diabetes at a tertiary hospital in Riyadh, Saudi Arabia

[22] Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia

[23] Association of MBL2 gene polymorphisms with pulmonary tuberculosis susceptibility: trial sequence meta-analysis as evidence

[24] Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses

[25] Forecasting the seasonality and trend of pulmonary tuberculosis in Jiangsu Province of China using advanced statistical time-series analyses

[26] Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report

[27] Association of MBL2 gene polymorphisms with pulmonary tuberculosis susceptibility: trial sequence meta-analysis as evidence

[28] Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones

[29] Sera from patients with active pulmonary tuberculosis and their household contacts induce nuclear changes in neutrophils

[30] The correlation between CT features and glycosylated hemoglobin level in patients with T2DM complicated with primary pulmonary tuberculosis

[31] Performance of computed tomography versus chest radiography in patients with pulmonary tuberculosis with and without diabetes at a tertiary hospital in Riyadh, Saudi Arabia

[32] Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia

[33] [PARADOXICAL RESPONSE DURING TREATMENT OF PULMONARY TUBERCULOSIS].

[34] A Hospital-based cross-sectional study on clinico-demographic characteristic of extrapulmonary tuberculosis cases coming to a tertiary hospital of Bihar

[35] Mass screening for active case finding of pulmonary tuberculosis in the Russian Federation: how to save costs.

[36] [Multidrug-resistant extrapulmonary tuberculosis: about 7 cases].

[37] A systematic review of the diagnostic accuracy of artificial intelligence-based computer programs to analyze chest x-rays for pulmonary tuberculosis.

[38] Duration of treatment in pulmonary tuberculosis: are international guidelines on the management of tuberculosis missing something?

[39] A first insight into genetic diversity of Mycobacterium bovis isolated from extrapulmonary tuberculosis patients in South Tunisia assessed by spoligotyping and MIRU VNTR.

[40] Primary drug resistance in extra-pulmonary tuberculosis: a hospital-based prospective study from Pakistan.

[41] Risk factors for mortality among inpatients with smear positive pulmonary tuberculosis.

[42] Socio-economic determinants of the family history of pulmonary tuberculosis patients in Pakistan

[43] FDG-PET/CT AS A NON-INVASIVE BIOMARKER FOR ASSESSING ADEQUACY OF TREATMENT AND PREDICTING RELAPSE IN PATIENTS TREATED FOR PULMONARY TUBERCULOSIS.

[44] [10-Years experience in the chemotherapy of pulmonary tuberculosis at the Medizinischen Universitatsklinik Freiburg].

[45] Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.

[46] Locally-secreted interleukin-6 is related with radiological severity in smear-negative pulmonary tuberculosis

[47] Genetic polymorphism rs8193036 of IL17A is associated with increased susceptibility to pulmonary tuberculosis in Chinese Han population

[48] Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment

[49] Prevalence of pulmonary tuberculosis in Wardha district of Maharashtra, Central India

[50] Comparison of serum neopterin levels in pulmonary tuberculosis patients with positive acid fast bacilli and inactive pulmonary tuberculosis.

[51] Accuracy and incremental yield of urine Xpert MTB/RIF Ultra versus Determine TB-LAM for diagnosis of pulmonary tuberculosis

[52] Comparison of CapitalBio™ Mycobacterium nucleic acid detection test and Xpert MTB/RIF assay for rapid diagnosis of extrapulmonary tuberculosis

[53] Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis

[54] Contribution of Real-Time Xpert MTB/RIF Testing to Establishing Early Diagnosis of Pediatric Extrapulmonary Tuberculosis in a Nonendemic Setting: A Case Series

[55] Utility of urine as a clinical specimen for the diagnosis of pulmonary tuberculosis in people living with HIV in Addis Ababa, Ethiopia

[56] Microbiological diagnosis of pulmonary tuberculosis in children by oral swab polymerase chain reaction

[57] Spoligotyping and drug sensitivity of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in the Arsi Zone of southeastern Ethiopia

[58] Use of GeneXpert MTB/RIF® on a single pooled sputum specimen to exclude pulmonary tuberculosis among hospital inpatients placed in respiratory isolation.

[59] Demographic risk factors for extra-pulmonary tuberculosis among adolescents and adults in Saudi Arabia.

[60] Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis.

[61] Diagnostic accuracy of nucleic acid amplification tests in urine for pulmonary tuberculosis: a meta-analysis.

[62] Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis.

[63] Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.

[64] Locally-secreted interleukin-6 is related with radiological severity in smear-negative pulmonary tuberculosis.

[65] Extrapulmonary Tuberculosis: Pathophysiology and Imaging Findings.

[66] Extrapulmonary tuberculosis: Pathophysiology and imaging findings

[67] Pulmonary tuberculosis and diabetes: Aspects of its epidemiology, pathophysiology, and symptoms

[68] Pulmonary thromboembolism in aids patient with chronic venous insufficiency, pulmonary tuberculosis and breast cancer: A case report and pathophysiology review

[69] Lack of Association between Interleukin-18 –607 C/A Gene Polymorphism and Pulmonary Tuberculosis in Zahedan, Southeast Iran

[70] Prevalence of pulmonary tuberculosis in India: A systematic review and meta-analysis.

[71] Performance of loop-mediated isothermal amplification assay in the diagnosis of pulmonary tuberculosis in a high prevalence TB/HIV rural setting in Uganda

[72] Characteristics of patients with smear-negative pulmonary tuberculosis (TB) in a region with high TB and HIV prevalence

[73] Prevalence of tuberculosis, HIV, and TB-HIV co-infection among pulmonary tuberculosis suspects in a predominantly pastoralist area, northeast Ethiopia

[74] Cost analysis of a nucleic acid amplification test in the diagnosis of pulmonary tuberculosis at an urban hospital with a high prevalence of TB/HIV

[75] Prevalence of HIV-TB co-infection and impact of HIV infection on pulmonary tuberculosis outcome in Togo

[76] Is pulmonary tuberculosis in pregnant women a problem in Ghana? Observations and lessons from the national tuberculosis prevalence project.

[77] Diagnostic Yield of Fluorescence and Ziehl-Neelsen Staining Techniques in the Diagnosis of Pulmonary Tuberculosis: A Comparative Study in a District Health Facility.

[78] Extra-pulmonary tuberculosis: A retrospective study of patients in Accra, Ghana.

[79] Is pulmonary tuberculosis in pregnant women a problem in Ghana? Observations and lessons from the national tuberculosis prevalence project

[80] The role of candidate miRNAs in T Cell response during acute pulmonary tuberculosis in Kumasi, Ghana

[81] Pulmonary tuberculosis

[82] Endocrines and pulmonary tuberculosis

[83] Pulmonary tuberculosis

[84] Pulmonary tuberculosis

[85] Pulmonary tuberculosis in practice

[86] Synopsis of pulmonary tuberculosis

[87] Pulmonary Tuberculosis

[88] Gastrointestinal Tuberculosis in Patients With Pulmonary Tuberculosis

[89] Less Common Forms of Extra-Pulmonary Tuberculosis

[90] Radionuclides in the Evaluation of Extra-Pulmonary Tuberculosis

[91] Pulmonary Tuberculosis in Monkeys

[92] Comorbidity: pulmonary tuberculosis and chronic obstructive pulmonary disease

[93] A method for the treatment of pulmonary tuberculosis by intra-pulmonary injections of gelatin acriflavine calcium chloride

[94] Interferonγ/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis

[95] Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.

[96] High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.

[97] 4-month moxifloxacin containing regimens in the treatment of patients with sputum-positive pulmonary tuberculosis in South India - a randomised clinical trial.

[98] Treatment of Isoniazid-Resistant Pulmonary Tuberculosis.

[99] A Case of Persistent Air Leak Managed by Selective Left Main Bronchus Intubation in an Infant with Pulmonary Tuberculosis.

[100] Sputum Conversion Among Patients With Smear Positive Pulmonary Tuberculosis

[101] Pulmonary tuberculosis incidence and drug resistance-related factors analysis in North China